Keros Net Working Capital from 2010 to 2024
| KROS Stock | USD 46.87 0.56 1.21% |
Net Working Capital | First Reported 2010-12-31 | Previous Quarter 322.9 M | Current Value 203.6 M | Quarterly Volatility 122.4 M |
Check Keros TherapeuticsInc financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Keros main balance sheet or income statement drivers, such as Tax Provision of 0.0, Net Interest Income of 0.0 or Interest Income of 3.1 M, as well as many exotic indicators such as Price To Sales Ratio of 7.3 K, Dividend Yield of 0.0 or PTB Ratio of 3.35. Keros financial statements analysis is a perfect complement when working with Keros TherapeuticsInc Valuation or Volatility modules.
Keros | Net Working Capital |
Latest Keros TherapeuticsInc's Net Working Capital Growth Pattern
Below is the plot of the Net Working Capital of Keros TherapeuticsInc over the last few years. It is Keros TherapeuticsInc's Net Working Capital historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Keros TherapeuticsInc's overall financial position and show how it may be relating to other accounts over time.
| Net Working Capital | 10 Years Trend |
|
Net Working Capital |
| Timeline |
Keros Net Working Capital Regression Statistics
| Arithmetic Mean | 95,127,854 | |
| Geometric Mean | 34,267,991 | |
| Coefficient Of Variation | 128.62 | |
| Mean Deviation | 109,370,606 | |
| Median | 14,062,000 | |
| Standard Deviation | 122,350,288 | |
| Sample Variance | 14969.6T | |
| Range | 318.5M | |
| R-Value | 0.79 | |
| Mean Square Error | 5971.1T | |
| R-Squared | 0.63 | |
| Significance | 0.0004 | |
| Slope | 21,708,320 | |
| Total Sum of Squares | 209574.3T |
Keros Net Working Capital History
About Keros TherapeuticsInc Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Keros TherapeuticsInc income statement, its balance sheet, and the statement of cash flows. Keros TherapeuticsInc investors use historical funamental indicators, such as Keros TherapeuticsInc's Net Working Capital, to determine how well the company is positioned to perform in the future. Although Keros TherapeuticsInc investors may use each financial statement separately, they are all related. The changes in Keros TherapeuticsInc's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Keros TherapeuticsInc's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Keros TherapeuticsInc Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Keros TherapeuticsInc. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Working Capital | 322.9 M | 203.6 M |
Pair Trading with Keros TherapeuticsInc
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Keros TherapeuticsInc position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Keros TherapeuticsInc will appreciate offsetting losses from the drop in the long position's value.Moving together with Keros Stock
| 0.89 | EQ | Equillium | PairCorr |
Moving against Keros Stock
| 0.66 | VALN | Valneva SE ADR | PairCorr |
The ability to find closely correlated positions to Keros TherapeuticsInc could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Keros TherapeuticsInc when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Keros TherapeuticsInc - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Keros TherapeuticsInc to buy it.
The correlation of Keros TherapeuticsInc is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Keros TherapeuticsInc moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Keros TherapeuticsInc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Keros TherapeuticsInc can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Keros TherapeuticsInc Correlation against competitors. For more information on how to buy Keros Stock please use our How to Invest in Keros TherapeuticsInc guide.You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Complementary Tools for Keros Stock analysis
When running Keros TherapeuticsInc's price analysis, check to measure Keros TherapeuticsInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Keros TherapeuticsInc is operating at the current time. Most of Keros TherapeuticsInc's value examination focuses on studying past and present price action to predict the probability of Keros TherapeuticsInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Keros TherapeuticsInc's price. Additionally, you may evaluate how the addition of Keros TherapeuticsInc to your portfolios can decrease your overall portfolio volatility.
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |
Is Keros TherapeuticsInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Keros TherapeuticsInc. If investors know Keros will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Keros TherapeuticsInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.15) | Revenue Per Share 0.007 | Return On Assets (0.26) | Return On Equity (0.40) |
The market value of Keros TherapeuticsInc is measured differently than its book value, which is the value of Keros that is recorded on the company's balance sheet. Investors also form their own opinion of Keros TherapeuticsInc's value that differs from its market value or its book value, called intrinsic value, which is Keros TherapeuticsInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Keros TherapeuticsInc's market value can be influenced by many factors that don't directly affect Keros TherapeuticsInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Keros TherapeuticsInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Keros TherapeuticsInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Keros TherapeuticsInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.